Date printed: 12/01/2019
H-B-Vax II
Details for H-B-Vax II vaccine and its components.
Sponsor:
Merck Sharp & Dohme (Australia)
Administration route:
Intramuscular injection
Vaccine group:
Monovalent vaccines
Registered for use from birth.
Recombinant hepatitis B vaccine
Adult formulation
Each 1.0 mL monodose vial or pre-filled syringe contains:
- 10 µg recombinant hepatitis B surface antigen (HBsAg) protein, adsorbed onto 0.5 mg aluminium hydroxide
Paediatric formulation
Each 0.5 mL monodose vial or pre-filled syringe contains:
- 5 µg recombinant HBsAg protein, adsorbed onto 0.25 mg aluminium hydroxide
Dialysis formulation
Each 1.0 mL monodose vial contains:
- 40 µg recombinant HBsAg protein, adsorbed onto 0.5 mg aluminium hydroxide
All formulations contain latex and may contain yeast proteins.
The product information and consumer medicine information for H-B-Vax II have more details.
Audience:
Infants and children
Page history
Last updated:
4 June 2018
Last reviewed:
4 June 2018
Definitions
- HBsAg
- hepatitis B surface antigen
This document was printed on: 24/01/2019. Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/vaccines/h-b-vax-ii.